Shenzhen Neptunus Interlong Bio-Technique (08329) Releases January 2026 Monthly Return
Bulletin Express
Feb 02
Shenzhen Neptunus Interlong Bio-Technique Company Limited (stock code: 08329) published its monthly return for the period ended 31 January 2026. The authorized share capital held steady at 426,000,000 H shares with a par value of RMB 0.1 each, totaling RMB 42.6 million. No change was recorded in the number of issued H shares, which remained at 426,000,000.
Additionally, the company’s domestic shares stood unchanged at 1,252,000,000. Public float requirements at the prescribed 25% threshold were confirmed to be met. No share options, warrants, convertibles, nor any other arrangements to issue additional shares were reported during this period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.